Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors

• The influence of adamantyl moiety on the properties of HDAC inhibitors was investigated.
• The derivatives showed a substantial reduction of inhibitory activity toward HDACs 1–11.
• They showed antiproliferative and proapoptotic activity comparable to that of compounds lacking the adamantyl group.
• A selected compound exhibited an appreciable in vivo antitumor activity against HCT116.

To investigate the influence of the adamantyl group on the biological properties of known HDAC inhibitors with a 4-phenylcinnamic skeleton, a series of compounds having the adamantyl moiety in the cap structure were synthesized and compared to the corresponding hydroxamic acids lacking this group. An unexpected finding was the substantial reduction of inhibitory activity toward the tested enzymes, in particular HDAC6, following the introduction of the adamantyl group. In spite of the reduced ability to function as HDAC inhibitors, the compounds containing the adamantyl moiety still retained a good efficacy as antiproliferative and proapoptotic agents. A selected compound (2c; ST3056) of this series exhibited an appreciable antitumor activity against the colon carcinoma xenograft HCT116.

Figure optionsDownload as PowerPoint slide